Logo image of IBG

INNOVATION BEVERAGE GROUP LT (IBG) Stock Fundamental Analysis

NASDAQ:IBG - Nasdaq - AU0000226177 - Common Stock - Currency: USD

0.7155  -0.03 (-4.65%)

After market: 0.779 +0.06 (+8.87%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to IBG. IBG was compared to 32 industry peers in the Beverages industry. IBG has a bad profitability rating. Also its financial health evaluation is rather negative. IBG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

IBG had negative earnings in the past year.
In the past year IBG had a positive cash flow from operations.
IBG Yearly Net Income VS EBIT VS OCF VS FCFIBG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -1M -2M -3M -4M

1.2 Ratios

IBG has a Return On Assets of -45.43%. This is amonst the worse of the industry: IBG underperforms 89.66% of its industry peers.
With a Return On Equity value of -915.64%, IBG is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -45.43%
ROE -915.64%
ROIC N/A
ROA(3y)-43.53%
ROA(5y)N/A
ROE(3y)-558.21%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBG Yearly ROA, ROE, ROICIBG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 65.27%, IBG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for IBG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBG Yearly Profit, Operating, Gross MarginsIBG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

IBG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IBG has about the same amount of shares outstanding.
IBG has a better debt/assets ratio than last year.
IBG Yearly Shares OutstandingIBG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
IBG Yearly Total Debt VS Total AssetsIBG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

IBG has an Altman-Z score of -1.74. This is a bad value and indicates that IBG is not financially healthy and even has some risk of bankruptcy.
IBG has a Altman-Z score of -1.74. This is amonst the worse of the industry: IBG underperforms 82.76% of its industry peers.
The Debt to FCF ratio of IBG is 51.50, which is on the high side as it means it would take IBG, 51.50 years of fcf income to pay off all of its debts.
IBG's Debt to FCF ratio of 51.50 is on the low side compared to the rest of the industry. IBG is outperformed by 75.86% of its industry peers.
A Debt/Equity ratio of 1.60 is on the high side and indicates that IBG has dependencies on debt financing.
IBG has a Debt to Equity ratio of 1.60. This is in the lower half of the industry: IBG underperforms 75.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 51.5
Altman-Z -1.74
ROIC/WACCN/A
WACC8.45%
IBG Yearly LT Debt VS Equity VS FCFIBG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M

2.3 Liquidity

IBG has a Current Ratio of 0.81. This is a bad value and indicates that IBG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of IBG (0.81) is worse than 79.31% of its industry peers.
A Quick Ratio of 0.50 indicates that IBG may have some problems paying its short term obligations.
IBG has a worse Quick ratio (0.50) than 72.41% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.5
IBG Yearly Current Assets VS Current LiabilitesIBG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.21% over the past year.
The Revenue for IBG has decreased by -30.52% in the past year. This is quite bad
EPS 1Y (TTM)51.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.21%
Revenue 1Y (TTM)-30.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IBG Yearly Revenue VS EstimatesIBG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2025 2026 1M 2M 3M 4M
IBG Yearly EPS VS EstimatesIBG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2025 2026 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

IBG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IBG Price Earnings VS Forward Price EarningsIBG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, IBG is valued a bit more expensive than the industry average as 68.97% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 209.01
EV/EBITDA N/A
IBG Per share dataIBG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IBG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVATION BEVERAGE GROUP LT

NASDAQ:IBG (1/31/2025, 8:00:01 PM)

After market: 0.779 +0.06 (+8.87%)

0.7155

-0.03 (-4.65%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners24.62%
Ins Owner ChangeN/A
Market Cap5.97M
AnalystsN/A
Price Target4.08 (470.23%)
Short Float %3.1%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.9
P/FCF 209.01
P/OCF 198.25
P/B 27.13
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.48%
OCF(TTM)0
OCFY0.5%
SpS0.38
BVpS0.03
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -45.43%
ROE -915.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.27%
FCFM 0.91%
ROA(3y)-43.53%
ROA(5y)N/A
ROE(3y)-558.21%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.6
Debt/FCF 51.5
Debt/EBITDA N/A
Cap/Depr 0.61%
Cap/Sales 0.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.5
Altman-Z -1.74
F-Score5
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)114.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.05%
OCF growth 3YN/A
OCF growth 5YN/A